Effects of CYP3A4 inhibition/induction, and OATP inhibition on the pharmacokinetics of atogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crossover trials

被引：0
|
作者：
Boinpally, R. [1 ]
Chen, W. [1 ]
McGeeney, D. [1 ]
Trugman, J. M. [1 ]
机构：
[1] AbbVie, Madison, NJ USA
来源：
HEADACHE | 2022年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-120
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] Effects of CYP3A4 inhibition/induction and OATP inhibition on the pharmacokinetics of atogepant in healthy adults
    Boinpally, Ramesh
    Chen, Wayne
    Mcgeeney, Danielle
    Trugman, Joel M.
    PAIN MANAGEMENT, 2023,
  • [2] Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects
    Wrishko, Rebecca E.
    McCrea, Jacqueline B.
    Yee, Ka Lai
    Liu, Wen
    Panebianco, Deborah
    Mangin, Eric
    Chakravarthy, Manu
    Martinez-Cantarin, Maria P.
    Kraft, Walter K.
    CLINICAL DRUG INVESTIGATION, 2019, 39 (05) : 441 - 451
  • [3] Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects
    Rebecca E. Wrishko
    Jacqueline B. McCrea
    Ka Lai Yee
    Wen Liu
    Deborah Panebianco
    Eric Mangin
    Manu Chakravarthy
    Maria P. Martinez-Cantarin
    Walter K. Kraft
    Clinical Drug Investigation, 2019, 39 : 453 - 454
  • [4] Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib
    Cardona, Panli
    Dutta, Sandeep
    Houk, Brett
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 810 - 818
  • [5] A Single-Center, Open-Label, Fixed-Sequence Clinical Study to Evaluate the Pharmacokinetic Effects of Supaglutide on Digoxin or Metformin in Healthy Subjects
    He Jinjie
    Zhang Jing
    Anwar, Dilbar
    Wu Haiya
    Wang, Qinghua
    Wu, Xiaojie
    DIABETES, 2024, 73
  • [6] Pharmacokinetics of Sugammadex: An Open-Label, 3-Period, Fixed-Sequence, 3-Single-Doses Study in Healthy Chinese Subjects
    Yuan, Fei
    Yang, Mengjie
    Chen, Weili
    Chen, Hanjing
    Xu, Hongrong
    Li, Hui
    Sheng, Lei
    Li, Xuening
    Ellen Wrishko, Rebecca
    Joel Woolf, Eric
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (03): : 333 - 340
  • [7] A phase 1 open-label fixed-sequence two-period crossover study of the effect of multiple doses of tamoxifen on palbociclib (PD-0332991) pharmacokinetics in healthy male volunteers
    Hoffman, Justin T.
    O'Gorman, Melissa
    Loi, Cho-Ming
    Plotka, Anna
    Boutros, Tanya
    Kirkovsky, Leonid
    Stampino, Corrado Gallo
    Wang, Diane
    CANCER RESEARCH, 2014, 74 (19)
  • [8] A phase I open-label, fixed-sequence, two-period crossover study of the effect of multiple doses of Itraconazole on Palbociclib (PD-0332991) pharmacokinetics in healthy volunteers
    Hoffman, Justin T.
    Loi, Cho-Ming
    O'Gorman, Melissa
    Plotka, Anna
    Kosa, Maha
    Jakubowska, Anna
    Wang, Diane D.
    CANCER RESEARCH, 2016, 76
  • [9] A PHASE 1, OPEN-LABEL, FIXED-SEQUENCE, CROSSOVER STUDY TO EVALUATE THE INTERACTION OF MULTIPLE-DOSE ODEVIXIBAT WITH THE PHARMACOKINETICS OF SINGLE-DOSE COMBINED ORAL CONTRACEPTIVE STEROIDS IN HEALTHY FEMALE PARTICIPANTS
    Mazuir, Florent
    Ordonez, Claudia
    Wallefors, Terese
    Zhu, Judy
    Lindstrom, Erik
    HEPATOLOGY, 2024, 80 : S1773 - S1774
  • [10] Evaluation of potential drug interactions with sodium zirconium cyclosilicate: a single-center, open-label, one sequence crossover study in healthy adults
    Nagard, Mats
    Kramer, William G.
    Boulton, David W.
    CLINICAL KIDNEY JOURNAL, 2021, 14 (07) : 1808 - 1816
12345